Haruhiko Akiyama

Haruhiko Akiyama

Auto-generated profile, based on publicly available information

Haruhiko Akiyama

Department of Orthopaedic Surgery, Gifu University Graduate School of Medicine, Gifu, Japan

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HAHaruhiko Akiyama
Haruhiko Akiyama
JKJung-Eun Kim
Jung-Eun Kim
KNKazuhisa Nakashima
Kazuhisa Nakashima
GBGener Balmes
Gener Balmes
NINaomi Iwai
Naomi Iwai
BCBenoit de Crombrugghe
Benoit de Crombrugghe
The transcription factor Sox9 is expressed in all chondroprogenitors and has an essential role in chondrogenesis. Sox9 is also expressed in other tissues, including central nervous system, neural crest, intestine, pancreas, testis, and endocardial cushions, and plays a crucial role in cell proliferation and differentiation in several of these tissues. To determine the cell fate of Sox9 -expressing cells during mouse embryogenesis, we generated mice in which a Cre recombinase gene preceded by an internal ribosome entry site was inserted into the 3′ untranslated region of the Sox9 gene ( Sox9-Cre knock-in). In the developing skeleton, Sox9 was expressed before Runx2 , an early osteoblast marker gene. Cell fate mapping by using Sox9-Cre;ROSA26 reporter ( R26R ) mice revealed that Sox9 -expressing limb bud mesenchymal cells gave rise to both chondrocytes and osteoblasts. Furthermore, a mutant in which the Osterix gene was inactivated in Sox9 -expressing cells exhibited a lack of endochondral and intramembranous ossification and a lack of mature osteoblasts comparable with Osterix -null mutants. In addition, Sox9 -expressing limb bud mesenchymal cells also contributed to tendon and synovium formation. By using Sox9-Cre ; R26R mice, we also were able to systematically follow Sox9 -expressing cells from embryonic day 8.0 to 17.0. Our results showed that Sox9 -expressing cells contributed to the formation of all cell types of the spinal cord, epithelium of the intestine, pancreas, and mesenchyme of the testis. Thus, our results strongly suggest that all osteo-chondroprogenitor cells, as well as progenitors in a variety of tissues, are derived from Sox9-expressing precursors during mouse embryogenesis.

6 August 2014 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
MMMasami Masuda-Suzukake
Masami Masuda-Suzukake
TNTakashi Nonaka
Takashi Nonaka
MHMasato Hosokawa
Masato Hosokawa
MKMaki Kubo
Maki Kubo
ASAki Shimozawa
Aki Shimozawa
MHMasato Hasegawa
Masato Hasegawa
α-Synuclein is the major component of filamentous inclusions that constitute the defining characteristic of Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy, so-called α-synucleinopathies. Recent studies revealed that intracerebral injection of recombinant α-synuclein fibrils into wild-type mouse brains induced prion-like propagation of hyperphosphorylated α-synuclein pathology. However, the propagation mechanisms of α-synuclein have not been fully elucidated. In this study, in order to establish where and how α-synuclein pathology propagates, we injected recombinant mouse α-synuclein fibrils into three different brain areas (substantia nigra, striatum, and entorhinal cortex) of wild-type mice and compared the resulting distributions of α-synuclein pathology at 1 month after injection. Distinct patterns of pathology were observed in mice injected at the different sites. Within one month after injection, the pathology had spread to neurons in areas far from the injection sites, especially areas with direct neural connections to the injection sites. Surprisingly, phosphorylated tau and TDP-43 pathologies were also observed in mice injected with α-synuclein fibrils into striatum and entorhinal cortex at one month after injection. Phosphorylated tau and TDP-43 were accumulated in dot-like inclusions, but these were rarely colocalized with α-synuclein pathology. It seems that accumulation of α-synuclein has a synergistic effect on tau and TDP-43 aggregation. Additionally, intracerebral injection with sarkosyl-insoluble fraction prepared from wild-type mice injected synthetic α-synuclein fibrils can also induce phosphorylated α-synuclein pathology in wild-type mice. Our data indicate that α-synuclein aggregation spread by prion-like mechanisms through neural networks in mouse brains.

30 August 2010 in Genesis
Verified
Journal Article
Closed access
PDF file
TSTsunemitsu Soeda
Tsunemitsu Soeda
JDJian Min Deng
Jian Min Deng
BCBenoit de Crombrugghe
Benoit de Crombrugghe
RBRichard R. Behringer
Richard R. Behringer
TNTakashi Nakamura
Takashi Nakamura
HAHaruhiko Akiyama
Haruhiko Akiyama

20 March 2008 in Modern Rheumatology
Verified
Journal Article
Closed access
PDF file
HAHaruhiko Akiyama
Haruhiko Akiyama
Cell-fate determination of pluripotent cells, cell proliferation, differentiation, and maturation, as well as the maintenance of stem cells, are essential cellular events during organogenesis. Previous reports show that some distinct cell-specific transcription factors are the master genes that control cell lineage commitment and the subsequent cell proliferation and differentiation. Some of these transcription factors generate hierarchical regulation of expression and act in concert to fulfill their roles. This review discusses the molecular properties and mechanisms of Sry-related high-mobility-group box (Sox) transcription factor, Sox9, in chondrogenesis.

19 May 2011 in Journal of Bone and Mineral Metabolism
Verified
Journal Article
Closed access
PDF file
HAHaruhiko Akiyama
Haruhiko Akiyama
VLVéronique Lefebvre
Véronique Lefebvre

22 March 2011 in Nature Communications
Verified
Journal Article
Open access
PDF file
YNYukio Nakamura
Yukio Nakamura
KYKoji Yamamoto
Koji Yamamoto
XHXinjun He
Xinjun He
BOBungo Otsuki
Bungo Otsuki
YKYoungwoo Kim
Youngwoo Kim
HAHaruhiko Akiyama
Haruhiko Akiyama
Sox9 is a direct transcriptional activator of cartilage-specific extracellular matrix genes and has essential roles in chondrogenesis. Mutations in or around the SOX9 gene cause campomelic dysplasia or Pierre Robin Sequence. However, Sox9-dependent transcriptional control in chondrogenesis remains largely unknown. Here we identify Wwp2 as a direct target of Sox9. Wwp2 interacts physically with Sox9 and is associated with Sox9 transcriptional activity via its nuclear translocation. A yeast two-hybrid screen using a cDNA library reveals that Wwp2 interacts with Med25, a component of the Mediator complex. The positive regulation of Sox9 transcriptional activity by Wwp2 is mediated by the binding between Sox9 and Med25. In zebrafish, morpholino-mediated knockdown of either wwp2 or med25 induces palatal malformation, which is comparable to that in sox9 mutants. These results provide evidence that the regulatory interaction between Sox9, Wwp2 and Med25 defines the Sox9 transcriptional mechanisms of chondrogenesis in the forming palate.